Biocon Biologics completes acquisition of Viatris' Global Biosimilars Business

Nov 30, 2022

Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has...

Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in stock and cash

Mar 01, 2022

Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a...

Indian pharmaceutical industry moving ahead from generics to biosimilars and MedTech

Jun 25, 2024

"From generics, we are now moving very fast into biosimilars. We are moving equally fast in MedTech. And you will see that in the...

SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America

Feb 25, 2026

San Jose [Costa Rica]/ Raichur (Karnataka) [India], February 25: SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd. (SBPL),...

Biocon Biologics and Voluntis join hands for global collaboration on digital therapeutics for insulins

Jul 21, 2020

Bengaluru (Karnataka) [India], July 21 : Biocon Biologics India Limited, a fully integrated 'pure-play' biosimilars company, a subsidiary of Biocon Ltd. on Tuesday announced...

India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference

Sep 24, 2021

Bengaluru (Karnataka) [India], September 24 (ANI/PRNewswire): With an overarching theme of 'Ideate and Innovate' and new prospects of Intellectual Property (IP) in the Indian...